|
|
| Line 1: |
Line 1: |
| {{CMG}}
| | #REDIRECT [[Diltiazem#Administration and Monitoring]] |
| | |
| | |
| | |
| ==Instructions for administration==
| |
| <br>
| |
| <font size="4">[[Atenolol indications#Exertional Angina Pectoris Due to Atherosclerotic Coronary Artery Disease or Angina Pectoris at Rest Due to Coronary Artery Spasm|Exertional Angina Pectoris Due to Atherosclerotic Coronary Artery Disease or Angina Pectoris at Rest Due to Coronary Artery Spasm]]</font>
| |
| <br>
| |
| <br>
| |
| <font size="4">[[Atenolol indications#Concomitant Use with Other Cardiovascular Agents|Concomitant Use with Other Cardiovascular Agents]]</font>
| |
| <br>
| |
| <br>
| |
| -------
| |
| <br>
| |
| ===Exertional Angina Pectoris Due to Atherosclerotic Coronary Artery Disease or Angina Pectoris at Rest Due to Coronary Artery Spasm===
| |
| | |
| Dosage must be adjusted to each patient's needs. Starting with 30 mg four times daily, before meals and at bedtime, dosage should be increased gradually (given in divided doses three or four times daily) at one- to two-day intervals until optimum response is obtained. Although individual patients may respond to any dosage level, the average optimum dosage range appears to be 180 to 360 mg/day. There are no available data concerning dosage requirements in patients with impaired renal or hepatic function. If the drug must be used in such patients, titration should be carried out with particular caution.
| |
| | |
| ''[[Diltiazem instructions for administration#Instructions for administration|Return to top]]''
| |
| <br>
| |
| | |
| ===Concomitant Use with Other Cardiovascular Agents===
| |
| | |
| #Sublingual NTG may be taken as required to abort acute anginal attacks during Diltiazem therapy.
| |
| #Prophylactic Nitrate Therapy: Diltiazem may be safely coadministered with short- and long-acting nitrates, but there have been no controlled studies to evaluate the antianginal effectiveness of this combination. | |
| #Beta-blockers.
| |
| | |
| ''[[Diltiazem instructions for administration#Instructions for administration|Return to top]]''
| |
| <br>
| |
| | |
| | |
| | |
| | |
| | |
| | |
| {{FDA}}
| |
| | |
| | |
| | |
| | |
| [[Category:Drugs]]
| |